A randomized, double-blind, placebo-controlled, crossover study evaluated bone markers of formation and resorption in 17 overweight or obese men without T2DM who received sequence infusions of GIP alone, GLP-1 alone, a combination of GIP and GLP-1, and placebo [72]
Muscle loses sensitivity to protein, hormonal shifts occur, bone density declines, recovery slows, and cardiovascular tolerance narrows
In clinical practice, GLP-1 receptor agonists are used to manage type 2 diabetes and increasingly for weight-loss or metabolic indications
Alex Thomas and Dr
Cyltezo is indicated for all the same conditions as Humira, including moderate-to-severe rheumatoid arthritis, Crohns disease and ulcerative colitis